コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ction in antibody titers is possible through intradermal administration.
2 formulation, or placebo, by subcutaneous or intradermal administration.
3 ENvax, or placebo, by either subcutaneous or intradermal administration.
4 tion SARS-CoV-2 vaccines such as mucosal and intradermal administration.
5 controlled transdermal delivery and targeted intradermal administration.
6 n emergency use authorization was issued for intradermal administration (0.1 ml per dose); however, r
7 ent dose-response relation was observed with intradermal administration (1/3 dose subcutaneous GMFR 1
8 ythema and induration were more common after intradermal administration (31% erythema for full subcut
9 lumes that are considered to be standard for intradermal administration, and postulate a hydrodynamic
10 ne blue, patent blue, lower dye volumes, and intradermal administration are all associated with a low
12 f a simple, more tolerable, and dose-sparing intradermal administration followed by electroporation g
14 ed multimodal imaging in animal models using intradermal administration of (18)F-FDG for combined dia
15 ocal reactogenicity, whereas intravenous and intradermal administration of 10(6) to 10(8) CFU of rBCG
17 esponse due to MC deficiency was overcome by intradermal administration of a neutrophil chemoattracta
18 e to this IgG-mediated blistering disease by intradermal administration of a neutrophil chemoattracta
19 expressed in dorsal root ganglia (DRGs), and intradermal administration of a PI3Ky-selective inhibito
20 (CD44), the cognate hyaluronan receptor, and intradermal administration of A5G27, a CD44 receptor ant
26 er shelf-life than recombinant proteins, and intradermal administration of cDNA encoding IL-12 did no
37 versus 60.7 +/- 10.4%max, respectively) via intradermal administration of isoproterenol prior to LBN
40 a minimally invasive delivery system for the intradermal administration of nucleic acids, both plasmi
46 ointestinal symptoms that followed the first intradermal administration of the vaccine resembled thos
49 MTD of Nexvax2 was 150 mug for twice weekly intradermal administration over 8 weeks, which modified
50 antibody was given intraperitoneally whereas intradermal administration resulted in blisters only sli
52 vaccine formulations after intramuscular or intradermal administration was initially comparable; how
53 4) at 6 weeks post-vaccination compared with intradermal administration which resulted in a significa